This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains to many pages, the maxiumum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Kyle Rabe
Kyle Rabe
Associate
New York +1 212 841 1036 krabe@cov.com Download V-card

Kyle Rabe is a member of the firm’s corporate group and is resident in our New York office.  His experience includes mergers & acquisitions, takeover defenses, sports media transactions and private equity fund formation.

  • Represented the National Hockey League in negotiating its twelve-year, C$5.2 billion agreement with Rogers Communications for national broadcast and multimedia rights to NHL games, including the Stanley Cup Playoffs and the Stanley Cup Final, in Canada.
  • Represented Salix Pharmaceuticals in its $2.6 billion acquisition of Santarus, Inc.
  • Represented Aristocrat Leisure Limited in its $1.28 billion acquisition of Video Gaming Technologies.
  • Represented AstraZeneca in its acquisition of Bristol-Myers Squibb's interests in the companies’ diabetes alliance for an initial consideration of $2.7 billion on completion and up to $1.4 billion in regulatory, launch and sales-related payments.
  • Represented King Pharmaceuticals, Inc. in its $3.6 billion merger with Pfizer Inc.
  • Represented P. Schoenfeld Asset Management LP (PSAM) in its successful proxy contest to require a renegotiation of the terms of the business combination between MetroPCS and T-Mobile.
  • Represented SandRidge Energy Inc. in its response to a campaign by activist investor TPG-Axon to change control of the SandRidge board of directors.
  • Represented a US fund sponsor in the formation and marketing of a $1 billion private equity fund.
  • New York Super Lawyers, Mergers & Acquisitions and Business/Corporate "Rising Star" (2012-2014)